Recall archive / FDA drug enforcement
vancomycin added to 0.9% sodium chloride, 1.25 g/250 mL* (5 mg/mL), 250 mL per bag, Rx only, Central Admixture Pharma... — FDA record D-0720-2023
Reported terminated
Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.
Source date Apr 28, 2023. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.
Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.
What the record says
- Product
- vancomycin added to 0.9% sodium chloride, 1.25 g/250 mL* (5 mg/mL), 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-6074-1.
- Reason
- Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
- Classification
- Class II
- Recalling firm
- Central Admixture Pharmacy Services, Inc.
- Quantity
- 27780 bags
- Agency-reported status
- Terminated
- Source record identifier
- D-0720-2023
What the recall classes mean. Classification is an agency assessment, not individual medical advice.
Lot and product identifiers
| Label field | Details supplied by the agency |
|---|---|
| Lot, code or applicability | Lot # 37-883407, 37-883436, Exp 05/01/2023; 37-883796, 37-883797, 37-883800, 37-883802, 37-883806, Exp 05/02/2023; 37-884162, 37-884163, Exp 05/03/2023; 37-885332, 37-885336, 37-885337, Exp 05/08/2023; 37-885749, 37-885753, 37-885755, Exp 05/09/2023; 37-886008, 37-886027, 37-886031, 37-886035, Exp 05/10/2023; 37-886273, 37-886274, 37-886275, Exp 05/11/2023; 37-887448, 37-887457, Exp 05/16/2023; 37-887765, 37-887772, 37-887775, Exp 05/17/2023; 37-888062, 37-888072, Exp 05/18/2023; 37-888811, 37-888817, Exp 05/22/2023; 37-889193, 37-889208, 37-889210, Exp 05/23/2023; 37-889450, 37-889451, 37-889454, Exp 05/24/2023; 37-890940, 37-890941, 37-890952, Exp 05/30/2023; 37-891137, 37-891138, 37-891139, Exp 05/31/2023; 37-892633, 37-892634, 37-892635, Exp 06/06/2023; 37-892934, 37-892961, 37-892964, 37-892965, Exp 06/07/2023; 37-893524, Exp 06/11/2023; 37-893993, 37-893996, Exp 06/12/2023; 37-894465, 37-894466, 37-894467, 37-894468, Exp 06/13/2023; 37-894706, 37-894714, Exp 06/14/2023; 37-895680, 37-895682, Exp 06/19/2023; 37-896123, Exp 06/20/2023; 37-896564, 37-896579, 37-896586, Exp 06/21/2023 |
Match all identifying details in the current notice. A brand name alone is not enough.
Distribution
Nationwide in the USA.
States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.
- Alaska
- Alabama
- Arkansas
- Arizona
- California
- Colorado
- Connecticut
- Delaware
- Florida
- Georgia
- Hawaii
- Iowa
- Idaho
- Illinois
- Indiana
- Kansas
- Kentucky
- Louisiana
- Massachusetts
- Maryland
- Maine
- Michigan
- Minnesota
- Missouri
- Mississippi
- Montana
- North Carolina
- North Dakota
- Nebraska
- New Hampshire
- New Jersey
- New Mexico
- Nevada
- New York
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Virginia
- Vermont
- Washington
- Wisconsin
- West Virginia
- Wyoming
Dates in the source
- Report date
- May 31, 2023
- Recall initiation date
- Apr 28, 2023
- Center classification date
- May 19, 2023
- Termination date
- Jun 22, 2025
FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.